News

regulators; Infinity taps Medidata; and much more...

        Swiss CRO PSI is headed to this weekend's American Society of Hematology meeting, touting its experience in trials for breakthrough treatments for blood cancers. News

        > Indian drug manufacturer Wockhardt said it received U.K. clearance for a troubled production plant in Chikalthana. More

        > Infinity Pharmaceuticals ($INFI) enlisted Medidata ($MDSO) to help execute its Phase III cancer trial. Story



Excerpt from URL:https://www.fiercebiotech.com/cro/spotlight-on-psi-touts-its-hematology-expertise-wockhardt-clears-u-k-regulators-infinity-taps



  ▲ Last article:   PSI Offers to Stop Clinical Trial Delays in Hematology and Beyond ---Dec 3, 2015
  ▼ Next article:   Medidata reaches into South Korea with a CRO partnership ---Dec 2, 2015
                    More ……      

 



News FullText Search